# NB Capital

NB Capital is a Private Equity based in Copenhagen, Denmark.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Copenhagen, Denmark
- **Region:** Europe
- **Address:** Copenhagen, Denmark
- **Founded:** 2001
- **Assets under management:** Approximately $1B in discretionary capital (per firm website)
- **Website:** nbcapital.net
- **LinkedIn:** https://linkedin.com/company/nb-capital-aps

## Regulatory record

- **Reports private funds:** No

## About

Representative Investments by Florian Schönharting Role: Co-Founder Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer and autoimmune diseases, based on proprietary next generation antibody technologies. Ticker: GEN.CO - Market cap:

## Sectors

- Biotechnology
- Pharmaceuticals
- Life Sciences

## People

- Florian Schönharting — Chief Executive Officer

## Questions

### Who runs investment decisions at NB Capital?

CEO Florian Schönharting leads investment decisions. He co-founded Genmab and has deployed capital across the biopharma sector for more than 25 years, from seed-stage company formation to activist campaigns in large-cap public drug developers.

### How does NB Capital source proprietary deal flow?

The firm sources through Schönharting’s direct network as a serial biotech founder and board-level operator. By co-founding companies such as Genmab and Forward Pharma, the team accesses early-stage science and spin-out opportunities before they reach broad institutional auction processes.

### Does NB Capital participate in fund commitments or only direct deals?

The firm makes direct public and private equity investments. It has acted as founder, co-founder, seed investor, pre-IPO backer and activist public investor. There is no public indication that it commits capital to third-party venture or buyout funds.

### What investment stages does NB Capital typically target?

NB Capital invests across the full drug-development lifecycle, from seed and company formation through pre-IPO, public equity and activist campaigns. Its past deals include founding Forward Pharma, seed-investing in BioMarin, and running activist positions in Facet Biotech and Élan.

### Where does the underlying capital come from?

NB Capital was seeded in 2001 by experienced biotech investors and a pharmaceutical company. Its current investor base is globally spread across institutional investors, sovereign wealth funds and family offices.

## Related profiles

- [NBA Pension Plan For Coaches, Assistant Coaches and Trainers](https://altss.com/profile/nba-pension-plan-for-coaches-assistant-coaches-and-trainers)
- [NBC Securities](https://altss.com/profile/nbc-securities)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/nb-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology